glp 1 effect on gallbladder issues GLP-1 receptor agonists and disease risk: insights into molecular mechanisms and clinical implications GLP-1 and Increased Incidence of – Common GLP-1 side effects include

The 6.6 percentage-point gain from adding cagrilintide to semaglutide is the cleanest existing read on what amylin layering buys you on top of an incretin agonist

That makes it the single largest addressable market for incretin therapies, and domestic competition is intensifying fast

The Medicare GLP-1 Bridge program represents a historic shift in how the federal government views obesity treatment for beneficiaries, but its not clear what will happen beyond 18 months

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials